Fig. 3From: Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s diseasePearson correlation forest plots. A. CSF ApoA1 BBB markers in MCI group, B. CSF ApoA1 BBB markers in dementia group, C. Plasma ApoA1 BBB markers in MCI group, D. Plasma ApoA1 BBB markers in the dementia groupBack to article page